In a recent study titled “Mapping the Pareto Optimal Design Space for a Functionally Deimmunized Biotherapeutic Candidate”, published in PLOS Computational ... Read more
In a recent study titled “64Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by ... Read more
Intrexon Corporation has announced, together with ZIOPHARM Oncology, the signing of an exclusive licensing agreement with The University of Texas MD Anderson Cancer Center ... Read more
Cancer fighting chimeric antigen receptor (CAR) T cells, developed by Dr. Charles Sentman’s laboratory of Dartmouth’s Norris Cotton Cancer Center, are ... Read more
Celsion Corporation has announced the submission of its Phase I clinical trial protocol to the U.S. Food and Drug Administration (FDA) for ... Read more
A recent study, published in Nature Communications by King’s College London researchers, has identified a novel mechanism associated with skin damage ... Read more
Alex’s Lemonade Stand, a nonprofit organization, has awarded the Bio-therapeutics Impact Award to three individuals, including Baylor College of Medicine and ... Read more
Conkwest, Inc., a company developing the proprietary immunotherapeutic Natural Killer (NK) cell-line platform, Neukoplast (NK-92), has announced that physician scientist Dr. Patrick ... Read more
